Related Experiment Video
Updated: Jul 14, 2026

DNBS/TNBS Colitis Models: Providing Insights Into Inflammatory Bowel Disease and Effects of Dietary Fat
Published on: February 27, 2014
13-Oxo-ODE is an endogenous ligand for PPARgamma in human colonic epithelial cells
Reinhold Altmann1, Martin Hausmann, Tanja Spöttl
1Department of Internal Medicine I, University of Regensburg, 93042 Regensburg, Germany.
Background:
The ligand activated nuclear hormone receptor peroxisome proliferator-activated receptor gamma (PPARgamma) induces transcriptional repression of pro-inflammatory factors. Activation of PPARgamma is followed by amelioration of colitis in animal models of inflammatory bowel disease (IBD). A reduced expression of PPARgamma was found in epithelial cells of patients with ulcerative colitis. The eicosanoids 13-HODE and 15-HETE are products of 12/15-lipoxygenase (LOX) and endogenous ligands for PPARgamma. Dehydrogenation of 13-HODE by 13-HODE dehydrogenase results in formation of the 13-Oxo-ODE. Highest activity of 13-HODE dehydrogenase is found in colonic epithelial cells (CECs). We therefore investigated whether 13-Oxo-ODE is a new endogenous ligand of PPARgamma in CECs.
Methods:
LOX activity and 13-HODE dehydrogenase in CECs were investigated after stimulation with arachidonic or linoleic acid. LOX metabolites were identified by RP-18 reversed-phase HPLC. Binding of (14)C-labelled 13-Oxo-ODE was demonstrated using a His-tagged PPARgamma.
Results:
Stimulation of HT-29 and primary CECs homogenates with and without Ca-ionophor was followed by the formation of high amounts of the linoleic acid metabolite 13-Oxo-ODE (155 and 85 ng/ml). The decrease of IL-8 secretion from IEC was more pronounced after pre-incubation with 13-Oxo-ODE compared to the PPARgamma agonist troglitazone and higher as with the known PPARgamma ligands 13-HODE and 15-HETE. Binding assays with (14)C-labelled 13-Oxo-ODE clearly demonstrated a direct interaction.
Conclusion:
High amounts of 13-Oxo-ODE can be induced in CECs by stimulation of linoleic acid metabolism. 13-Oxo-ODE binds to PPARgamma and has anti-inflammatory effects. 13-HODE dehydrogenase might be a therapeutic target in IBD.
Insights
A novel compound, 13-Oxo-ODE, derived from linoleic acid metabolism in colonic epithelial cells (CECs), directly binds to peroxisome proliferator-activated receptor gamma (PPARgamma). This interaction demonstrates anti-inflammatory effects, suggesting 13-HODE dehydrogenase as a potential therapeutic target for inflammatory bowel disease (IBD).
Area of Science:
- Biochemistry
- Molecular Biology
- Gastroenterology
Background:
- Peroxisome proliferator-activated receptor gamma (PPARgamma) activation ameliorates colitis in inflammatory bowel disease (IBD) models.
- Reduced PPARgamma expression is observed in ulcerative colitis patients.
- 13-HODE and 15-HETE are endogenous PPARgamma ligands derived from 12/15-lipoxygenase (LOX).
Purpose of the Study:
- To investigate if 13-Oxo-ODE, a metabolite of 13-HODE, is a novel endogenous ligand for PPARgamma in colonic epithelial cells (CECs).
- To explore the anti-inflammatory potential of 13-Oxo-ODE in the context of IBD.
Main Methods:
- Investigated LOX activity and 13-HODE dehydrogenase in CECs after stimulation with linoleic acid.
- Identified LOX metabolites using RP-18 reversed-phase HPLC.
- Demonstrated binding of (14)C-labelled 13-Oxo-ODE to His-tagged PPARgamma.
Main Results:
- High amounts of 13-Oxo-ODE were formed in CECs upon stimulation of linoleic acid metabolism.
- 13-Oxo-ODE exhibited a more pronounced decrease in IL-8 secretion than troglitazone and known PPARgamma ligands.
- Binding assays confirmed direct interaction between 13-Oxo-ODE and PPARgamma.
Conclusions:
- 13-Oxo-ODE can be induced in CECs and binds to PPARgamma.
- 13-Oxo-ODE possesses anti-inflammatory properties.
- 13-HODE dehydrogenase presents a potential therapeutic target for IBD.
Related Concept Videos
Peroxisomes
Transducer Mechanism: Nuclear Receptors
About 48 different soluble family members of nuclear receptors are identified that can be divided into two main classes:
Regulation of the Unfolded Protein Response
Protein Import into the Peroxisomes
Peroxisomal Protein Import:
Peroxisomes lack the genetic machinery required to code for their own proteins. Hence, most peroxisomal membrane, lumenal and transmembrane proteins are synthesized in the cytoplasm or ER and transported to the peroxisome...
